VISANI, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 761
EU - Europa 370
AS - Asia 143
AF - Africa 1
Totale 1.275
Nazione #
US - Stati Uniti d'America 756
IT - Italia 143
IE - Irlanda 70
HK - Hong Kong 64
SE - Svezia 59
PL - Polonia 58
CN - Cina 38
JO - Giordania 21
RU - Federazione Russa 15
DE - Germania 9
SG - Singapore 9
GB - Regno Unito 8
CA - Canada 4
IN - India 4
BE - Belgio 3
JP - Giappone 2
PH - Filippine 2
UA - Ucraina 2
VN - Vietnam 2
AT - Austria 1
CZ - Repubblica Ceca 1
GL - Groenlandia 1
GR - Grecia 1
NG - Nigeria 1
TH - Thailandia 1
Totale 1.275
Città #
Fairfield 95
Chandler 87
Ashburn 79
Dublin 70
Warsaw 58
Woodbridge 54
Seattle 51
Hong Kong 48
Houston 46
Cambridge 41
Ann Arbor 38
Wilmington 35
Dearborn 25
Florence 25
Lawrence 24
Altamura 22
New York 22
Milan 15
Beijing 13
Moscow 13
Princeton 13
Buffalo 12
Boston 9
Medford 9
Kent 7
Rome 7
San Diego 7
Shanghai 5
West Jordan 5
Qingdao 4
San Quirino 4
Brussels 3
Cambiago 3
Fontebuona 3
Pontedera 3
Prato 3
Redwood City 3
St Louis 3
Toronto 3
Turin 3
Viterbo 3
Boardman 2
Campi Bisenzio 2
Cervignano del Friuli 2
Dong Ket 2
Empoli 2
Falls Church 2
Fiesole 2
Hillsboro 2
Lonate Ceppino 2
London 2
Nagold 2
Nanjing 2
Norwalk 2
Pavia 2
Scarperia e San Piero 2
Southwark 2
Trecate 2
Andover 1
Arezzo 1
Bologna 1
Boscoreale 1
Brescia 1
Cabanatuan City 1
Chengdu 1
Delhi 1
Enfield 1
Falkenstein 1
Frankfurt am Main 1
Gorgonzola 1
Guangzhou 1
Hangzhou 1
Hefei 1
Kilburn 1
Kumar 1
Lagos 1
Lucca 1
Nardò 1
New Bedfont 1
Nuuk 1
Phoenix 1
Piraeus 1
Ponte Buggianese 1
Prague 1
Pullach im Isartal 1
Pune 1
Quezon City 1
Singapore 1
Stockholm 1
Thiene 1
Verona 1
Vienna 1
Wuhan 1
Zhengzhou 1
Totale 1.043
Nome #
Efficacy and tolerability of cyberknife stereotactic robotic radiotherapy for primary or secondary orbital lesions: A single-center retrospective experience 154
Influence of age and subtype in outcome of operable liposarcoma 114
PO-0643: Scalp-sparing radiotherapy to minimize alopecia in patients with primary brain cancer 111
Exclusive endocrine therapy or partial breast irradiation for women aged ≥70  years with luminal A-like early stage breast cancer (NCT04134598 – EUROPA): Proof of concept of a randomized controlled trial comparing health related quality of life by patient reported outcome measures 106
A matched cohort study of radio-chemotherapy versus radiotherapy alone in soft tissue sarcoma patients 100
Phase 2 placebo-controlled, single-blind trial to evaluate the impact of oral ibandronate on bone mineral density in osteopenic breast cancer patients receiving adjuvant aromatase inhibitors: 5-year results of the single-centre BONADIUV trial 94
Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer 86
Hypofractionated whole breast irradiation after conservative surgery for patients aged less than 60 years: a multi-centre comparative study 76
Re-irradiation as salvage treatment in recurrent glioblastoma: A comprehensive literature review to provide practical answers to frequently asked questions 75
Outcome and prognostic factors for older patients undergoing radiosurgery for brain metastases 62
Prospective assessment of AR splice variant and multi-biomarker expression on circulating tumor cells of mCRPC patients undergoing androgen receptor targeted agents: interim analysis of PRIMERA trial (NCT04188275) 41
Cardioprotective Strategy for Patients with Nonmetastatic Breast Cancer Who Are Receiving an Anthracycline-Based Chemotherapy: A Randomized Clinical Trial 36
Pre-pectoral breast reconstruction: early and long-term safety evaluation of 146 unselected cases of the early pre-pectoral era of a single-institution, including cases with previous breast irradiation and post-mastectomy radiation therapy 34
Is there a worthwhile value in personalizing radiation therapy for breast cancer patients? Time for a new paradigm in the older adult population 34
Integrating radiation therapy with targeted treatments for breast cancer: From bench to bedside 32
Predictive factors for tolerance to taxane based chemotherapy in older adults affected by metastatic prostate cancer (ANCHISES-NCT05471427): A prospective observational trial including patients with metastatic hormone sensitive and castrate resistant prostate cancer treated with taxane chemotherapy 27
Safety of CDK4/6 inhibitors and concomitant radiation therapy in patients affected by metastatic breast cancer 23
Preoperative robotic radiosurgery for early breast cancer: Results of the phase II ROCK trial (NCT03520894) 18
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results 16
PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective study 12
Essential requirements for reporting radiation therapy in breast cancer clinical trials: An international multi-disciplinary consensus endorsed by the European Society for Radiotherapy and Oncology (ESTRO) 10
Three Months' PSA and Toxicity from a Prospective Trial Investigating STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence after Prostatectomy-STARR (NCT05455736) 10
Safety profile of trastuzumab-emtansine (T-DM1) with concurrent radiation therapy: a systematic review and meta-analysis 9
Safety profile of cyclin-dependent kinase (CDK) 4/6 inhibitors with concurrent radiation therapy: A systematic review and meta-analysis 9
Stereotactic reirradiation with CyberknifeR for locally recurrent prostate cancer, long-term toxicity and clinical outcomes from a monocentric cohort 8
International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendations 7
Cancer Treatment-Related Complications in Patients With Hypertrophic Cardiomyopathy 3
Totale 1.307
Categoria #
all - tutte 5.493
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.493


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201937 0 0 0 0 0 0 0 0 0 0 19 18
2019/2020296 10 18 5 18 50 42 40 29 30 17 22 15
2020/2021155 16 8 6 24 4 15 7 10 18 18 12 17
2021/2022129 3 9 9 8 4 4 7 18 8 4 17 38
2022/2023384 26 86 33 8 22 70 44 36 45 2 11 1
2023/2024283 15 24 26 22 21 45 16 68 19 20 7 0
Totale 1.307